Provided by Tiger Trade Technology Pte. Ltd.

Information

5.19
+0.12002.37%
Post-market: 5.190.0042+0.08%18:01 EDT
Volume:159.87K
Turnover:828.61K
Market Cap:251.27M
PE:21.64
High:5.21
Open:5.12
Low:5.09
Close:5.07
52wk High:6.45
52wk Low:3.74
Shares:48.41M
Float Shares:35.55M
Volume Ratio:0.94
T/O Rate:0.45%
Dividend:0.18
Dividend Rate:3.47%
EPS(TTM):0.2399
EPS(LYR):0.1900
ROE:12.30%
ROA:6.36%
PB:2.62
PE(LYR):27.32

Loading ...

Congress Members Ask Insurers for Information on Credit-Based Home Insurance

Dow Jones
·
Aug 05

Minority Shareholder Sues Ege Gübre Over Information Rights

TIPRANKS
·
Aug 04

Creative Realities, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call Information

GlobeNewswire
·
Aug 04

ISG Says German Enterprises Reshape Private, Hybrid Clouds to Support AI Workloads

Reuters
·
Aug 04

ASX Midday Sector Update: Information Technology Stocks Jump, Consumer Staples Sector Slides

MT Newswires Live
·
Aug 04

Ascletis Pharma Shares Surge 5% on Global Phase 3 Trial Launch for GLP-1 Oral Drug ASC30

Deep News
·
Aug 04

Information Services Group Inc Expected to Post Earnings of 9 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Neurotech raises $4.5m to fund pivotal ASD Phase III trial

TIPRANKS
·
Aug 04

Enav Updates Governance Procedures on Inside Information and Internal Dealing

TIPRANKS
·
Aug 04

Press Release: Attorney General James Sues Trump Administration to Protect Vulnerable New Yorkers' Personal Information

Dow Jones
·
Aug 04

Inflection Point Acquisition Corp III trading resumes

TIPRANKS
·
Aug 04

China Renaissance Starts Hygon Information Technology at Buy with 500 Yuan Price Target

MT Newswires Live
·
Aug 03

Shanghai Fosun Pharmaceutical Secures Regulatory Approval for Diabetes Combination Drug

Stock News
·
Aug 03

Mirle Automation Corp Appoints Chief Information Security Officer; Shares Jump 10%

MT Newswires Live
·
Aug 03

Arbitration Uncertainty Resolved as Phase 3 Data Readout Nears; 3D189 Rights for 3D Medicines Face Value Reassessment

Stock News
·
Aug 03

Huahai Pharmaceutical's Four Drugs Recommended for China's Centralized Drug List

MT Newswires Live
·
Aug 03

Plum Acquisition Corp III shifts incorporation to Canada

TIPRANKS
·
Aug 01

Tera Yatırım Formalizes Information Policy to Strengthen Market Transparency

TIPRANKS
·
Aug 01

Tenax Therapeutics: Buy Rating Ahead of August LEVEL Phase III Catalyst, Attractive Risk/Reward in Underserved PH-HFpEF Market

TIPRANKS
·
Aug 01

Research Alliance Corporation III trading halted, volatility trading pause

TIPRANKS
·
Jul 31